Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Apr 03, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.14
Apr 03, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.01
Apr 03, 2018
Director
Director Other acquisition or disposition -- --
Apr 03, 2018
Director
Director Other acquisition or disposition -- --
Apr 03, 2018
Director
Director Other acquisition or disposition -- --
Apr 03, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.33
Apr 03, 2018
Director
Director Other acquisition or disposition -- --
Apr 03, 2018
Director
Director Other acquisition or disposition -- --
Apr 02, 2018
Chief Operating Officer
Chief Operating Officer Other acquisition or disposition -- --
Apr 02, 2018
Chief Operating Officer
Chief Operating Officer Open market or private sale of non-derivative or derivative security 1,948 $15.58
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 29, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.61
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 29, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.18
Mar 29, 2018
Director
Director Other acquisition or disposition -- --
Mar 28, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 4,350 $16.35
Mar 28, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 28, 2018
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 4,810 $16.40
Mar 26, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 26, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 1,300 $17.38
Mar 26, 2018
Chief Operating Officer
Chief Operating Officer Other acquisition or disposition -- --
Mar 26, 2018
Chief Operating Officer
Chief Operating Officer Open market or private sale of non-derivative or derivative security 220 $17.41

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.